News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
575,018 Results
Type
Article (33336)
Company Profile (156)
Press Release (541522)
Multimedia
Podcasts (115)
Webinars (22)
Section
Business (167398)
Career Advice (1896)
Deals (25924)
Drug Delivery (86)
Drug Development (70983)
Employer Resources (121)
FDA (13577)
Job Trends (11537)
News (282157)
Policy (25184)
Tag
Academia (2164)
Academic (2)
Accelerated approval (12)
Adcomms (17)
Allergies (106)
Alliances (43302)
ALS (141)
Alzheimer's disease (1424)
Antibody-drug conjugate (ADC) (242)
Approvals (13819)
Artificial intelligence (443)
Autoimmune disease (107)
Automation (28)
Bankruptcy (205)
Best Places to Work (9498)
BIOSECURE Act (17)
Biosimilars (135)
Biotechnology (106)
Bladder cancer (131)
Brain cancer (50)
Breast cancer (502)
Cancer (3926)
Cardiovascular disease (319)
Career advice (1614)
Career pathing (34)
CAR-T (223)
CDC (34)
Cell therapy (617)
Cervical cancer (28)
Clinical research (60702)
Collaboration (1372)
Company closure (3)
Compensation (810)
Complete response letters (30)
COVID-19 (2064)
CRISPR (73)
C-suite (621)
Cystic fibrosis (121)
Data (5164)
Decentralized trials (2)
Denatured (40)
Depression (85)
Diabetes (404)
Diagnostics (5077)
Digital health (33)
Diversity (8)
Diversity, equity & inclusion (37)
Drug discovery (210)
Drug pricing (126)
Drug shortages (24)
Duchenne muscular dystrophy (173)
Earnings (71581)
Editorial (48)
Employer branding (15)
Employer resources (110)
Events (94471)
Executive appointments (887)
FDA (16025)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (3)
Frontotemporal dementia (18)
Funding (1185)
Gene editing (150)
Generative AI (42)
Gene therapy (468)
GLP-1 (753)
Government (3395)
Grass and pollen (6)
Guidances (354)
Healthcare (14688)
HIV (40)
Huntington's disease (31)
IgA nephropathy (66)
Immunology and inflammation (181)
Immuno-oncology (21)
Indications (66)
Infectious disease (2263)
Inflammatory bowel disease (167)
Inflation Reduction Act (13)
Influenza (90)
Intellectual property (182)
Interviews (357)
IPO (12764)
IRA (42)
Job creations (2438)
Job search strategy (1344)
Kidney cancer (12)
Labor market (55)
Layoffs (380)
Leadership (30)
Legal (5775)
Liver cancer (69)
Longevity (9)
Lung cancer (565)
Lymphoma (304)
Machine learning (30)
Management (40)
Manufacturing (562)
MASH (142)
Medical device (9785)
Medtech (9811)
Mergers & acquisitions (14067)
Metabolic disorders (956)
Multiple sclerosis (136)
NASH (13)
Neurodegenerative disease (241)
Neuropsychiatric disorders (49)
Neuroscience (2365)
NextGen: Class of 2025 (4824)
Non-profit (3623)
Now hiring (30)
Obesity (403)
Opinion (246)
Ovarian cancer (132)
Pain (145)
Pancreatic cancer (160)
Parkinson's disease (226)
Partnered (22)
Patents (363)
Patient recruitment (330)
Peanut (43)
People (49834)
Pharmaceutical (43)
Pharmacy benefit managers (19)
Phase I (18738)
Phase II (26605)
Phase III (20154)
Pipeline (3296)
Policy (209)
Postmarket research (2346)
Preclinical (7943)
Press Release (59)
Prostate cancer (211)
Psychedelics (28)
Radiopharmaceuticals (241)
Rare diseases (586)
Real estate (4128)
Recruiting (50)
Regulatory (19183)
Reports (32)
Research institute (2077)
Resumes & cover letters (290)
Rett syndrome (21)
RNA editing (9)
RSV (58)
Schizophrenia (119)
Series A (199)
Series B (137)
Service/supplier (6)
Sickle cell disease (70)
Special edition (17)
Spinal muscular atrophy (127)
Sponsored (32)
Startups (2710)
State (1)
Stomach cancer (11)
Supply chain (75)
Tariffs (56)
The Weekly (74)
Vaccines (774)
Venture capital (52)
Weight loss (257)
Women's health (52)
Worklife (15)
Date
Today (113)
Last 7 days (501)
Last 30 days (2690)
Last 365 days (28080)
2025 (26597)
2024 (30670)
2023 (34075)
2022 (43577)
2021 (46459)
2020 (43778)
2019 (37257)
2018 (27809)
2017 (26666)
2016 (25664)
2015 (29991)
2014 (24462)
2013 (20824)
2012 (21231)
2011 (21459)
2010 (20254)
Location
Africa (691)
Alabama (75)
Alaska (6)
Arizona (173)
Arkansas (11)
Asia (34355)
Australia (5380)
California (9286)
Canada (2555)
China (888)
Colorado (379)
Connecticut (424)
Delaware (292)
Europe (78966)
Florida (1287)
Georgia (300)
Hawaii (2)
Idaho (39)
Illinois (680)
India (49)
Indiana (428)
Iowa (20)
Japan (334)
Kansas (105)
Kentucky (30)
Louisiana (16)
Maine (38)
Maryland (1136)
Massachusetts (6940)
Michigan (256)
Minnesota (437)
Mississippi (4)
Missouri (88)
Montana (25)
Nebraska (20)
Nevada (94)
New Hampshire (44)
New Jersey (2626)
New Mexico (25)
New York (2480)
North Carolina (1216)
North Dakota (10)
Northern California (4444)
Ohio (273)
Oklahoma (20)
Oregon (32)
Pennsylvania (1815)
Puerto Rico (8)
Rhode Island (42)
South America (970)
South Carolina (39)
South Dakota (1)
Southern California (3662)
Tennessee (143)
Texas (1402)
United States (33033)
Utah (256)
Vermont (1)
Virginia (224)
Washington D.C. (76)
Washington State (744)
West Virginia (3)
Wisconsin (94)
Wyoming (2)
575,018 Results for "r and d biopharmaceuticals gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Merck Abandons $1.3B R&D Center in London, Boots 125 Employees
Claiming that the domestic market undervalues pharma innovation, Merck has decided to pull the plug on all of its R&D efforts in the U.K.
September 11, 2025
·
1 min read
·
Tristan Manalac
Labor market
Massachusetts R&D, Biomanufacturing Jobs Fell in ’24: Report
Massachusetts biopharma workforce growth was fairly flat last year, and R&D and manufacturing employment declined, according to a new MassBio report.
BioSpace
data further highlight challenges facing the state, showing roughly 2,300 people out of work in 2025 and jobs live on the website falling.
August 27, 2025
·
6 min read
·
Angela Gabriel
Press Releases
Croma-Pharma GmbH Enters Strategic Distribution Partnership with Renellence in Canada
October 10, 2025
·
2 min read
Business
Maryland’s Life Sciences Scene Boasts Strong R&D, Manufacturing Talent
The Washington, D.C.–Baltimore area ranks in the top six for life sciences R&D and manufacturing talent, according to a CBRE report. The Maryland Department of Commerce’s director of life sciences discusses the workforce and how the state is adapting to changing needs.
July 24, 2025
·
4 min read
·
Angela Gabriel
Press Releases
Nxera Pharma to Host R&D Day 2025
November 4, 2025
·
2 min read
Press Releases
IBA integrates Artificial Intelligence Quality Assurance into dosimetry solutions through the acquisition of PhantomX GmbH
November 3, 2025
·
2 min read
Press Releases
Candel Therapeutics to Host Virtual R&D Event on December 5, 2025
November 18, 2025
·
9 min read
Press Releases
HUTCHMED Highlights Pipeline and Business Progress at R&D Updates Event
November 2, 2025
·
9 min read
Clinical research
Undeterred by Political, Economic Headwinds, Pharma Ups R&D Investment in 2024 and Beyond
R&D spending across the global pharmaceutical sector climbed 1.5% in 2024, according to unreleased data from Evaluate Pharma.
May 28, 2025
·
12 min read
·
Tristan Manalac
Press Releases
Nurix Therapeutics Appoints Accomplished Biopharmaceutical Leader Roger Dansey, M.D., to Its Board of Directors
November 10, 2025
·
5 min read
1 of 57,502
Next
